Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an announcement.
PuraPharm Corporation Limited has announced the appointment of Dr. Kam Biu Tsoi as an executive director effective June 30, 2025. Dr. Tsoi, who has over 40 years of experience in sales management and Chinese medicine, will also join the company’s nomination committee. His appointment is expected to strengthen the company’s leadership in the Chinese medicine sector, given his extensive background and previous association with the company.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company involved in the Chinese medicine and healthcare products industry. It focuses on the development, production, and sales of traditional Chinese medicine products.
Average Trading Volume: 117,268
Technical Sentiment Signal: Sell
Current Market Cap: HK$189.6M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.